Oldenburger E, Brown S, Willmann J, et al. ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases. Radiother Oncol. 2022;173:240–53.
Article CAS PubMed Google Scholar
Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7:4–12.
Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomized trial. Lancet. 2005;366:643–8.
NCCN guidelines available at http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 16 Aug 2023. cns.
Spratt DE, Beeler WH, de Moraes FY, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an international spine oncology consortium report. Lancet Oncol. 2017;18:e720–30.
Imano N, Saito T, Hoskin P, et al. Pain response rates after conventional radiation therapy for bone metastases assessed using international consensus pain response endpoints: a systematic review and meta-analysis of initial radiation therapy and reirradiation. Int J Radiat Oncol Biol Phys. 2023;116:739–46.
Chow E, Hoskin P, Mitera G, et al. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys. 2012;82:1730–7.
Benzil DL, Saboori M, Mogilner AY, et al. Safety and efficacy of stereotactic radiosurgery for tumors of the spine. J Neurosurg. 2004;101:413–8.
Bilsky MH, Yamada Y, Yenice KM, et al. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report. Neurosurgery. 2004;54:823–30 (discussion 830-1).
Chang EL, Shiu AS, Lii M-F, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2004;59:1288–94.
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Orthod. 2020;38:2830–8.
Sahgal A, Myrehaug SD, Siva S, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomized, controlled, phase 2/3 trial. Lancet Oncol. 2021;22:1023–33.
Song X, Wei J, Sun R, et al. Stereotactic body radiation therapy versus conventional radiation therapy in pain relief for bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2022;115:909–21.
Myrehaug S, Sahgal A, Hayashi M, et al. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. 2017;27:428–35.
Chow E, van der Linden YM, Roos D, et al. Reiradiation: Single versus multiple fractions of repeat radiation for painful bone metastases: a randomized, controlled, non-inferiority trial. Lancet Oncol. 2014;15:164–71.
Murray L, Thompson C, Pagett C, et al. Treatment plan optimisation for reirradiation. Radiother Oncol. 2023;182:109545.
Sahgal A, Chang JH, Ma L, et al. Spinal cord dose tolerance to stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2021;110:124–36.
Nieder C, Grosu AL, Andratschke NH, et al. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys. 2006;66(5):1446–9.
Kirkpatrick JP, Van Der Kogel AJ, Schultheiss TE, et al. Radiation dose–volume effects in the spinal cord. Int J Radiat Oncol Biol Phys. 2010;76:S42–9.
Sahgal A, Ma L, Weinberg V, et al. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:107–16.
Cassidy V, Amdur RJ. Esophageal damage from thoracic spine stereotactic body radiation therapy. Pract Radiat Oncol. 2022;12:392–6.
Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale: clinical article. J Neurosurg Spine. 2010;13:324–8.
Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. 2010;35:E1221–9.
Cox BW, Spratt DE, Lovelock M, et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83:e597-605.
Redmond KJ, Lo SS, Soltys SG, et al. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine. 2017;26:299–306.
Koide Y, Shimizu H, Miyauchi R, et al. Fully automated rigid image registration versus human registration in postoperative spine stereotactic body radiation therapy: a multicenter non-inferiority study. J Radiat Res. 2022;63:115–21.
Shimizu H, Koide Y, Sasaki K, et al. Dosimetric analysis on computed tomography myelography based treatment planning in stereotactic body radiotherapy for spinal metastases. Med Dosim. 2023;48:187–92.
Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol. 2010;40:107–11.
Article PubMed PubMed Central Google Scholar
Niibe Y, Chang JY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med. 2012;2012: 261096.
Article PubMed PubMed Central Google Scholar
Niibe Y, Jingu K, Onishi H. Oligo-recurrence and Sync-oligometastases. J Thorac Oncol. 2018;13:e59–60.
Sahgal A, Ames C, Chou D, et al. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. 2009;74:723–31.
Choi CYH, Adler JR, Gibbs IC, et al. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord. Int J Radiat Oncol Biol Phys. 2010;78:499–506.
Garg AK, Shiu AS, Yang J, et al. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. 2012;118:5069–77.
Damast S, Wright J, Bilsky M, et al. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. Int J Radiat Oncol Biol Phys. 2011;81:819–26.
Mahadevan A, Floyd S, Wong E, et al. Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. Int J Radiat Oncol Biol Phys. 2011;81:1500–5.
Ahmed KA, Stauder MC, Miller RC, et al. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012;82:e803–9.
Chang U-K, Cho W-I, Kim M-S, et al. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol. 2012;51:589–95.
Thibault I, Al-Omair A, Masucci GL, et al. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture: clinical article. J Neurosurg Spine. 2014;21:711–8.
Hashmi A, Guckenberger M, Kersh R, et al. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. 2016;25:646–53.
Boyce-Fappiano D, Elibe E, Zhao B, et al. Reirradiation of the spine with stereotactic radiosurgery: efficacy and toxicity. Pract Radiat Oncol. 2017;7:e409–17.
Ito K, Nihei K, Shimizuguchi T, et al. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression. J Neurosurg Spine. 2018;29:332–8.
Sasamura K, Suzuki R, Kozuka T, et al. Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study. J Radiat Res. 2020;61:929–34.
Comments (0)